首页> 外国专利> Differential induction, maintenance and regulation of cd8+ t cell response against a model antigen expressed by an acute versus a chronic intracellular bacterium

Differential induction, maintenance and regulation of cd8+ t cell response against a model antigen expressed by an acute versus a chronic intracellular bacterium

机译:对急性和慢性细胞内细菌表达的模型抗原的cd8 + t细胞应答的差异诱导,维持和调节

摘要

The invention disclosed relates to CD8+ T cell response against a model antigen, Ovalbumin (Ova¿257-264?) expressed by Listeria monocytogenes (LM, inducing an acute infection, 7 days) versus Mycobacterium bovis (BCG, inducing a chronic infection, 150 days). Lower doses of both pathogens induced stronger bacterial growth but weaker T cell memory indicating that memory correlates with pathogen dose but not with bacterial expansion. LM-Ova induced a rapid effector response followed by a rapid, but massive attrition. BCG-Ova on the other hand, induced a slower, but chronic, effector response followed by a gradual decline thereafter. CD8?+¿ T cell response induced by BCG-Ova was highly dependent on pathogen-persistence as removal of BCG-Ova by antibiotics compromised CD8+ T cell frequency suggesting that persistence of antigen is important for protective CD8+ T cell memory. In spite of a stronger initial T cell response with LM-Ova, BCG-Ova provided more effective tumor (B16Ova) control at both local and distal sites due to the induction of a persistently activated acquired and a more potent innate immunity. Thus, the state of memory CD8+ T cells rather than the number of memory CD8+ T cells is important for tumor control and expression of tumor antigens in BCG represents an ideal strategy for ensuring the maintenance of memory CD8+ T cells in a persistently activated state. Additionally, the expression of anti-apoptotic and memory promoting cytokine IL-15 by BCG results in continuous IL-15 expression in vivo and further enhancement of CD8+ T cell memory.
机译:公开的发明涉及相对于牛分枝杆菌(BCG,诱导慢性感染)针对单核细胞增生性李斯特菌(LM,诱导急性感染,<7天)表达的针对模型抗原卵清蛋白(Ova?257-264?)的CD8 + T细胞应答。 > 150天)。两种病原体的较低剂量诱导更强的细菌生长,但T细胞记忆力较弱,表明该记忆与病原体剂量相关,但与细菌膨胀无关。 LM-Ova引起快速的效应反应,随后发生快速但大量的消耗。另一方面,BCG-Ova诱导了较慢的但慢性的效应器反应,此后逐渐下降。 BCG-Ova诱导的CD8 + T细胞反应高度依赖病原体的持久性,因为抗生素去除BCG-Ova损害了CD8 + T细胞的频率,表明抗原的持久性对于保护性CD8 + T细胞的记忆很重要。尽管用LM-Ova增强了初始T细胞反应,但由于诱导了持续激活的获得性和更有效的先天免疫,BCG-Ova在局部和远端部位均提供了更有效的肿瘤(B16Ova)控制。因此,记忆CD8 + T细胞的状态而不是记忆CD8 + T细胞的数目对于肿瘤控制很重要,并且在BCG中肿瘤抗原的表达代表了确保记忆CD8 + T细胞维持在持续激活状态的理想策略。另外,BCG表达的抗凋亡和促进记忆的细胞因子IL-15导致体内IL-15的连续表达并进一步增强了CD8 + T细胞的记忆。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号